Advertisement

Topics

Latest "Global TitaniumIV Isopropoxide 546689 Market Data Survey Report" News Stories

14:30 EDT 23rd March 2019 | BioPortfolio

Here are the most relevant search results for "Global TitaniumIV Isopropoxide 546689 Market Data Survey Report" found in our extensive news archives from over 250 global news sources.

More Information about Global TitaniumIV Isopropoxide 546689 Market Data Survey Report on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Global TitaniumIV Isopropoxide 546689 Market Data Survey Report for you to read. Along with our medical data and news we also list Global TitaniumIV Isopropoxide 546689 Market Data Survey Report Clinical Trials, which are updated daily. BioPortfolio also has a large database of Global TitaniumIV Isopropoxide 546689 Market Data Survey Report Companies for you to search.

Showing "Global TitaniumIV Isopropoxide 546689 Market Data Survey Report" News Articles 1–25 of 45,000+

Saturday 23rd March 2019

Patisiran therapy reduces ventricular myocardial strain in hereditary transthyretin amyloidosis

1. Use of patisiran, an RNA interference therapy, in patients with hereditary transthyretin (hATTR) cardiac amyloidosis was linked to reduced left ventricular global longitudinal strain (LVGLS) compared with placebo. 2. The therapy-associated reduction in ventricular myocardial strain was greatest for the basal region. The mid and apical regions of the LV did not have significant […] So...


Opinion: “Global warming is the biggest public health threat of the 21st century and is going to change life on earth as we know it. It is an essential part of any 21st century medical school curriculum." https://buff.ly/2YfXJEk 

Opinion: “Global warming is the biggest public health threat of the 21st century and is going to change life on earth as we know it. It is an essential part of any 21st century medical school curriculum." https://buff.ly/2YfXJEk 

Over One Third of Type 1 Diabetes Patients Quit Closed-Loop System

Real-world data show MiniMed 670G (the 'artificial pancreas') is difficult to use for those with type 1 diabetes, with technical problems forcing many to quit within a few months. Medscape Medical News


City of Hope Study Finds Popular Diabetes Diagnosis Test Misses Most Cases

The study was presented at ENDO 2019, Endocrine Society’s annual meeting The hemoglobin A1c blood test is widely used to diagnose type 1 and type 2 diabetes, but it is actually unable to detect the disease in most patients, according to a new study presented Saturday, March 23, at a news conference at ENDO 2019, the Endocrine Society’s annual meeti...

Isagenix Celebrates 17 Years of Transforming Lives With Limited-Edition Meal Replacement Protein Shake

GILBERT, Ariz. (PRWEB) March 22, 2019 Isagenix International , a global health and wellness company providing nutrition and lifestyle solutions, is celebrating 17 years of business and transformed lives with the limited-edition Birthday Cake Flavor IsaLean® Shake . Available in the Uni...

HeartMate 3: Superior Results Hold Firm in Final Analysis (CME/CE)

(MedPage Today) -- MOMENTUM 3 data confirms better safety for newer LVAD in advanced heart failure

Radius Health Presents Analysis from Phase 3 ACTIVE Trial and Data from Preclinical Studies for ...

-Post-hoc analysis suggests abaloparatide may be useful in the treatment of women with postmenopausal osteoporosis and concurrent osteoarthritis, at high risk for fracture- -Preclinical studies provide explanations for the net bone gain observed in the Phase 3 ACTIVE trial in abaloparatide-treated patients- WALTHAM, Mass., March 23, 2019 (GLOBE NEWSWIRE) Read more...

News digest – hot tea, cancer doctor shortages, junk food ad ban proposals and baby Grady  

Science blog Hot tea headlines miss crucial details Hot drinks hit the headlines this week after a study sparked claims that hot

The March 2019 Edition of the Crystallography Times Newsletter Is Online

Crystallography Times vol. 11, No. 3, from Rigaku Oxford Diffraction, focusing on single crystal X-ray diffraction, is available from the company’s website. THE WOODLANDS, Texas (PRWEB) March 23, 2019 The newest edition of Crystallography Times from Rigaku Corporation has been published and is now available on the company’s global website. Crystallography Times is a monthly electronic newslet...

Friday 22nd March 2019

SeqOnce Biosciences Launches RhinoSeq™ Rapid DNA Library Preparation Kit

SeqOnce Biosciences Inc. launches its new RhinoSeq™ DNA Library Preparation Kit for Next Generation Sequencing (NGS) sample preparation. PASADENA, Calif. (PRWEB) March 22, 2019 SeqOnce Biosciences Inc. launches its new RhinoSeq™ DNA Library Preparation Kit for Next Generation Sequencing (NGS) sample preparation. RhinoSeq employs a proprietary kit chemistry that makes it the fastest DNA librar...

[Articles] Three-dimensional visualisation of the fetal heart using prenatal MRI with motion-corrected slice-volume registration: a prospective, single-centre cohort study

Standard fetal MRI with open-source image processing software is a reliable method of generating high-resolution 3D imaging of the fetal vasculature. The 3D volumes produced show good spatial agreement with ultrasound, and significantly improved visualisation and diagnostic quality compared with source 2D MRI data. This freely available combination requires minimal infrastructure, and provides saf...

[Viewpoint] When ethics and politics collide in donor-funded global health research

In this Viewpoint, we share our experience of censorship in evaluation research for global health. Our experience shows a broader trend of donors and implementing partners who deliberately use ethical and methodological arguments to undermine essential research. In a context of chronic underfunding of universities and their growing dependence on donor-driven research grants, we propose several str...

[Correspondence] Keeping promises to women, children, and adolescents

By 2015, at the end of the Millennium Development Goals (MDGs) era, each year more than 6 million children younger than 5 years and 1 million adolescents were dying each year and more than 300 000 maternal deaths were occurring every year.1 These deaths are a substantial health problem and social injustice because most cases are preventable and are concentrated in rural populations and poorer co...

Engineers at @RutgersU report the creation of flexible, lightweight materials with 4D printing that could lead to small implantable biomedical devices (with video): http://ow.ly/ep1r30o9re9 

Engineers at @RutgersU report the creation of flexible, lightweight materials with 4D printing that could lead to small implantable biomedical devices (with video): http://ow.ly/ep1r30o9re9 

Radius Health Presents Analysis from Phase 3 ACTIVE Trial and Data from Preclinical Studies for TYMLOS® (abaloparatide) Injection at ENDO 2019 Annual Meeting

-Post-hoc analysis suggests abaloparatide may be useful in the treatment of women with postmenopausal osteoporosis and concurrent osteoarthritis, at high risk for fracture- -Preclinical studies provide explanations for the net bone gain observed in the Phase 3 ACTIVE trial in abaloparatide-treated patients- WALTHAM, Mass., March 23, 2019 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS)...

Regenerative Fuel Cell RFC Global Market Research and Forecast, 20152025 [Report Updated: 01011970] Prices from USD $2200

SummaryThe Regenerative Fuel Cell RFC report provides an independent information about the Regenerative Fuel Cell RFC industry supported by extensive research on factors such as industry segmentssize trends, inhibitors, dynamics, drivers, opportunities challenges, environment policy, cost overview, porter's five force analysis, and key companies profiles including business overview and recent...

Shaggy, Big Freedia Headline Saturday’s Florida AIDS Walk & Music Festival, on Track to Raise $1.5M

AHF’s 14th annual Florida AIDS Walk and Music Festival on March 23rd and set to nearly $1.5 million, will benefit 10 non-profits that provide HIV/AIDS services in South Florida, the nation’s epicenter for HIV. Multi Grammy award-winning, reggae artist Shaggy and the Queen of bounce music, Big Freedia will join an array of performers over the spring...

Navidea Biopharmaceuticals Announces Stock Purchase Agreement; Other Business Updates

Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced execution of a Stock Purchase Agreement (the “Purchase Agreement”) with an existing investor, John K. Scott, Jr. (the “Investor”), pursuant to ...

WuXi AppTec Reports Strong 2018 Annual Results

Revenue RMB9,614 Million, up 23.8% (25.4% at Constant Exchange Rate) Year-Over-Year Net Profit Attributable to Owners of the Company RMB2,261 Million, up 84.2% Year-Over-Year Diluted EPS RMB 2.21, up 70.0% Year-Over-Year SHANGHAI, March 22, 2019 /PRNewswire/ -- WuXi AppTec Co., Ltd. (stock code: 603259.SH / 0235...

Gossamer Bio Announces 2018 Annual Financial Results

Gossamer Bio, Inc. (Nasdaq:GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, today announced its financial results for the year ended December 31, 2018 and provided an update on recent corporate developments. ...

Teva Announces Launch of a Generic Version of EXJADE® (deferasirox) Tablets For Oral Suspension in the United States

Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of a generic version of EXJADE®1 (deferasirox) Tablets for Oral Suspension, 125 mg, 250 mg and 500 mg, in the U.S. Deferasirox Tablets for Oral Suspension are an iron chelator indicated for the treatment of chronic iron overload due to blood transfusions in ...

Sanofi: FDA issues Complete Response Letter for Zynquista(TM) (sotagliflozin)

FDA issues Complete Response Letter for Zynquista(TM) (sotagliflozin) PARIS and THE WOODLANDS, TX -  March 22, 2019 -  The U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding the New Drug Application for investigational Zynquista(TM) (sotagliflozin)*, a dual SGLT1 and SGLT2 inhibitor for the treatment of adults with type 1 diabetes in combi...

What Burnout? Survey Finds Docs Are Happy at Work

(MedPage Today) -- Must reads about the latest news and trends in healthcare careers

The Week That Wasn't: Brain Infection, Plastic Surgery Rates, Memory and Intelligence

Find out about a man who developed an infection in the lining of his brain after cleaning his ears, details on a plastic surgery annual statistics report, and a study suggesting that forgetfulness is a sign of intelligence. Medscape

Hikma launches Levophed generic


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks